Filter
1599
Filtered Results: 1599
Text search:
Femal
Health
Company
Featured
Recommendations
174
New Publications
464
Language
Document type
No document type
941
Studies & Reports
277
Guidelines
201
Manuals
83
Strategic & Response Plan
51
Training Material
19
Fact sheets
14
Situation Updates
5
Infographics
4
Brochures
3
App
1
Countries / Regions
Global
73
India
58
Nepal
37
Western and Central Europe
36
Liberia
29
Sierra Leone
28
Nigeria
28
Bangladesh
26
Myanmar / Burma
25
Kenya
22
Asia
21
South Africa
21
Ukraine
20
Ethiopia
20
Rwanda
19
Syria
19
Africa
19
Uganda
19
Latin America and the Carribbean
18
Zambia
18
Malawi
17
Philippines
17
South–East Asia Region
16
Ghana
15
Eastern Europe
15
Indonesia
15
Mozambique
12
Tanzania
12
Germany
12
Congo, Democratic Republic of
12
Namibia
12
Senegal
11
Yemen
10
South Sudan
10
Zimbabwe
9
Cambodia
9
Botswana
8
Lesotho
7
Guinea
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Moldova
6
Russia
6
North Macedonia
5
Cameroon
5
Afghanistan
5
China
4
Venezuela
4
Jordan
4
Middle East and North Africa
4
Brazil
4
Sudan
4
Georgia
4
Somalia
4
Tajikistan
3
Serbia
3
Benin
3
Albania
3
Kyrgyzstan
3
Armenia
3
USA
3
Haiti
3
Western Pacific Region
3
Paraguay
3
North America
3
East and Southern Africa
3
Lebanon
3
Vietnam
3
Central African Republic
3
Libya
3
Iraq
3
Eswatini/ Swaziland
3
Colombia
2
Thailand
2
Kazakhstan
2
Uzbekistan
2
Peru
2
West and Central Africa
2
Southern Africa
2
Papua New Guinea
2
Sri Lanka
2
Romania
2
Palestine
2
Poland
2
Mali
2
Madagascar
2
Pakistan
2
Timor Leste/ East Timor
1
Mexico
1
Turkey
1
Gambia
1
Iran
1
Laos
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Hungary
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Tunisia
1
Azerbaijan
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Egypt
1
Greece
1
Angola
1
Bhutan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
178
Women & Child Health
157
Public Health
127
Key Resources
97
Capacity Building
32
Pharmacy & Technologies
20
Toolboxes
HIV
183
Mental Health
97
COVID-19
80
NTDs
62
TB
55
Caregiver
55
Disability
53
Conflict
47
Ebola & Marburg
40
Planetary Health
39
Rapid Response
33
Global Health Education
33
Refugee
30
Zika
24
AMR
24
NCDs
22
Pharmacy
20
Natural Hazards
18
Specific Hazards
14
Health Financing Toolbox
12
Polio
7
Cholera
5
Social Ethics
4
Malaria
1
This publication provides information for identifying, classifying, marking, labelling, packaging, documenting and refrigerating infectious substances for transportation and ensuring their safe delivery.
The document provides practical guidance to facilitate compliance with applicable international...
The End TB Strategie
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
To implement the set of recommendations on the marketing of foods and non-alcoholic beverages to children
With the growing obesity crisis among children, WHO and other public health advocates and consumer groups have called for restrictions on advertising of ‘unhealthy foods’ high in salt, ...
With the growing obesity crisis among children, WHO and other public health advocates and consumer groups have called for restrictions on advertising of ‘unhealthy foods’ high in salt, ...
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
HIV drug resistance , Users Manual
December 2017
17–24 November 2015
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
